We just wanted to say hi to the group as AllSeq has started posting to SEQanswers as an approved vendor. (Personally, I’ve been a part of SEQanswers since 2008 posting as scbaker). We follow all of the platforms and keep a close eye on the NGS market, so feel free to pick our brains if you’d like a neutral opinion on something you’ve read about. We’ve posted something over in the vendor forum if you’re interested in learning more about what we do.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...